Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
First received: October 28, 2013
Last updated: July 2, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||May 2018 (Final data collection date for primary outcome measure)|